celecoxib has been researched along with Sarcoma, Alveolar Soft Part in 1 studies
Sarcoma, Alveolar Soft Part: A variety of rare sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck regions of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1365)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conde, N | 1 |
| Cruz, O | 1 |
| Albert, A | 1 |
| Mora, J | 1 |
1 other study available for celecoxib and Sarcoma, Alveolar Soft Part
| Article | Year |
|---|---|
Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Celecoxib; Child, Preschool | 2011 |